Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990) has released an update.
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. has announced an upcoming Annual General Meeting (AGM) on June 20, 2024, detailing matters such as financial reports, re-appointment of auditors, and director remuneration plans. Shareholders are advised to consult with professionals if they have any doubts and are reminded to submit their proxy forms if they cannot attend. The circular does not serve as an investment invitation but as an informational guide for shareholders.
For further insights into HK:6990 stock, check out TipRanks’ Stock Analysis page.
